Teladoc Inc Stock News

A lot of things are going right, but there''s still one troublesome factor.

A lot of things are going right, but there's still one troublesome factor.

Most of the market's most-shorted stocks are rarely worth a purchase, but when they're leading, large-cap tech names, there does come a time. The post 3 Large-Cap Technology's Most-Shorted Stocks to B

Amid first-quarter struggles for growth stocks, some members of this category are trading at discounts relative to their histories of often lofty valuations. Perhaps surprisingly, some names with the

For this year, Teladoc Health (TDOC) projects total visits in the band of 18.5-20 million, indicating a rise from the 2021 level of 15.4 million.

Not on its own, at least not yet.

This isn''t how upgrades are supposed to work.

Teladoc Health was a pandemic darling. Does the investing thesis still hold up?

The tech giant is expanding Amazon Care.

Teladoc''s battered and bruised stock could have brighter days ahead.

Don''t give up on this healthcare stock just yet.

Upgrades For Douglas Emmett Inc (NYSE: DEI ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48, compared to year-ago quarter EPS of $0.40. At the moment, the stock has a 52-week-high of $36.97 and a 52-week-low of $29.38. Douglas Emmett closed at $32.18 at the end of the last trading period. According to Evercore ISI Group, the prior rating for Southwest Airlines Co (NYSE: LUV ) was changed from In-Line to Outperform. In the fourth quarter, Southwest Airlines showed an EPS of $0.14, compared to $1.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $64.75 and a 52-week-low of $38.66. Southwest Airlines closed at $42.32 at the end of the last trading period. According to DA Davidson, the prior rating for SciPlay Corp (NASDAQ: SCPL ) was changed from Neutral to Buy. SciPlay earned $0.09 in the fourth quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.29 and a 52-week-low of $10.75.

This isn't how upgrades are supposed to work.

Within the last quarter, Teladoc Health (NYSE: TDOC ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 5 6 0 0 Last 30D 1 0 0 0 0 1M Ago 2 5 5 0 0 2M Ago 0 0 1 0 0 3M Ago 0 0 0 0 0 These 14 analysts have an average price target of $100.36 versus the current price of Teladoc Health at $72.55, implying upside. Below is a summary of how these 14 analysts rated Teladoc Health over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the … Full story available on Benzinga.com

Teladoc Health was a pandemic darling. Does the investing thesis still hold up?